share_log

5 Analysts Assess Century Therapeutics: What You Need To Know

5 Analysts Assess Century Therapeutics: What You Need To Know

5位分析師評估Century Therapeutics:你需要知道的事情
Benzinga ·  06/04 11:00

Across the recent three months, 5 analysts have shared their insights on Century Therapeutics (NASDAQ:IPSC), expressing a variety of opinions spanning from bullish to bearish.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings41000
Last 30D10000
1M Ago10000
2M Ago01000
3M Ago20000

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $13.6, a high estimate of $24.00, and a low estimate of $9.00. A decline of 2.86% from the prior average price target is evident in the current average.

price target chart

Investigating Analyst Ratings: An Elaborate Study

An...

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論